64
1
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T12927 | SK1-IN-1 | S1P Receptor | |
T30485 | SK1-I | BML 258,BML-258,BML258,BML-258 HCl | |
BML-258 HCl was removed and discontinued. | |||
T60798 | SK1- I hydrochloride | ||
SK1-I hydrochloride (BML-258 hydrochloride) is a sphingosine analog that can enhance autophagy and has antitumor activity. SK1-I hydrochloride is an isozyme-specific competitive SPHK1 inhibitor (Ki = 10 μM) [1] [2]. | |||
T12256 | NS8593 hydrochloride | NS8593 HCl | Potassium Channel |
NS8593 hydrochloride (NS8593 HCl) is a potent and selective inhibitor of small conductance Ca2+-activated K+ channels (SK channels) . | |||
T6085 | PF-543 | Sphingosine Kinase 1 Inhibitor II,PF 543 | Apoptosis , S1P Receptor , Autophagy , LPL Receptor |
PF-543 (Sphingosine Kinase 1 Inhibitor II), a novel sphingosine-competitive inhibitor of SphK1, inhibits SphK1 with IC50 and Ki of 2.0 nM and 3.6 nM. | |||
T8840 | PF-543 hydrochloride | PF-543 | Apoptosis , S1P Receptor , Autophagy , LPL Receptor |
PF-543 hydrochloride (PF-543) inhibits SphK1 with a K(i) of 3.6 nM, is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform. | |||
T9697 | ASK1-IN-1 | ASK | |
ASK1-IN-1 is an inhibitor of apoptosis signal-regulating kinase 1 which is a key mediator in the apoptotic and inflammatory cellular stress response with an IC50 of 21 nM in biochemica assays. | |||
T6003 | GSK1904529A | GSK 4529 | Apoptosis , Raf , VEGFR , IGF-1R , Syk |
GSK1904529A (GSK 4529) is a specific inhibitor of IGF-1R (IC50=27 nM) and IR(IC50=25 nM) . | |||
T67857 | ASK1-IN-4 | ASK | |
ASK1-IN-4 is an ASK1 inhibitor, IC50 = 0.2 μM. | |||
TQ0311 | GSK163090 | Dopamine Receptor , 5-HT Receptor | |
GSK163090 is a specific and orally active 5-HT1A/B/D receptor antagonist (pKis: 9.4/8.5/9.7, and 6.3/6.7 for 5-HT1A/B/D, and dopamine D2/D3). | |||
T3079 | GSK1838705A | IGF-1R , JNK , S6 Kinase , ALK | |
GSK1838705A is an effective IGF-1R inhibitor (IC50: 2.0 nM), modestly potent to IR (IC50: 1.6 nM) and ALK (IC50: 0.5 nM), respectively, and little inhibition to other protein kinases. | |||
T5427 | GSK1940029 | SCD inhibitor 1 | Dehydrogenase , Stearoyl-CoA Desaturase (SCD) |
GSK1940029 (SCD inhibitor 1) is a stearoyl-coa desaturase (SCD) inhibitor. | |||
T6848 | GSK1016790A | GSK101 | Calcium Channel , TRP/TRPV Channel |
GSK1016790A (GSK101) (GSK101) is a novel, potent activator of TRPV4 (transient receptor potential vanilloid 4) with EC50 of 34 nM in choroid plexus epithelial cells. | |||
T9377 | ASK1-IN-2 | Apoptosis , ASK , MAPK | |
ASK1-IN-2 is a potent and orally active inhibitor of apoptosis signal-regulating kinase 1 (ASK1), with an IC50 of 32.8 nM. ASK1-IN-2 can potentially be used as a therapeutic strategy for ulcerative colitis[1]. | |||
T27453 | GSK1733953A | DG70 | Antibacterial |
GSK1733953A can be used as a small molecule Mycobacterium tuberculosis respiration inhibitor with an inhibitory effect on MenG activity and an IC50 value of 2.6 ± 0.6 μM.GSK1733953A is a selective biphenylbenzamide with ... | |||
T24105 | GSK121 | GSK-121,GSK 121 | PAD |
GSK121 is an inhibitor of selective PAD4. | |||
T2079 | GSK126 | GSK2816126A,EZH2 inhibitor | Histone Methyltransferase |
GSK126 (GSK2816126A) is a excellently specific EZH2 methyltransferase inhibitor ( IC50=9.9 nM). | |||
T2701 | GSK1292263 | GPR | |
GSK1292263 is a GPR119 agonist and has been investigated for the treatment of DIABETES MELLITUS, TYPE 2. | |||
T3171 | GSK137647A | GSK 137647 | GPR |
GSK137647A (GSK 137647) is a selective FFA4 agonist. | |||
T2357 | GSK1059615 | GSK 1059615,GSK-1059615 | Apoptosis , PI3K , mTOR |
GSK1059615 has been used in trials studying the treatment of Lymphoma, Solid Tumours, Endometrial Cancer, Solid Tumor Cancer, and Metastatic Breast Cancer. | |||
TQ0066 | GSK189254A | GSK189254 | Histamine Receptor |
GSK189254A (GSK189254) is a potent and specific histamine H3 receptor antagonist (pKi values: 9.59-9.90 and 8.51-9.17 for human and rat H3). | |||
T37450 | SSK1 | p38 MAPK | |
SSK1 is a compound that selectively kills senescent cells and is a precursor for β-galactosidase, which can reduce the inflammatory response of the body. SSK1 can activate the phosphorylation of p38 MAPK and MKK3/MKK6 in... | |||
T6021 | GSK1324726A | I-BET726 | Apoptosis , Epigenetic Reader Domain |
GSK1324726A (I-BET726) is a greatly specific inhibitor of BET family proteins for BRD2(IC50=41 nM), BRD3(IC50=31 nM), and BRD4 (IC50=22 nM). | |||
T8861 | GSK199 | PAD | |
GSK199 is a selective PAD4 inhibitor(IC50 of 200 nM in the absence of calcium). | |||
T15424 | GSK1379725A | Epigenetic Reader Domain | |
GSK1379725A is a selective BPTF ligand (Kd: 2.8 uM). It also shows no binding activity for Brd4. | |||
T3513 | GSK180736A | GSK180736 | ROCK , GRK , PKA |
GSK180736A is an effective and selective GRK2 inhibitor (IC50: 0.77 μM) and >100-fold selectivity over other GRKs. It is a weak inhibitor of PKA (IC50: 30 μM), but highly effective against ROCK1 (IC50: 100 nM). | |||
T25467 | GSK1360707 | GSK-1360707,GSK 1360707 | |
GSK1360707 is a selective triple reuptake inhibitor (TRI). | |||
T27447 | GSK1104252A | GSK 1104252A,GSK-1104252A | |
GSK1104252A is a potent and selective agonist of GPR119. | |||
T24104 | GSK106 | GSK-106,GSK 106 | |
GSK106 is a negative control used in binding and functional assays for PAD4 inhibitors. | |||
T70171 | GSK1379767A | ||
GSK1379767A is a dual inhibitor of BPTF and Brd4. | |||
T35897 | ASK120067 | ||
ASK120067 is a potent and orally active inhibitor of EGFRT790M (IC50:0.3 nM) with selectivity over EGFRWT (IC50:6.0 nM). ASK120067 is a third-generation EGFR-TKI for the research of non-small cell lung cancer (NSCLC)[1]... | |||
T15426 | GSK180 | Hydroxylase | |
GSK180 is a selective competitive inhibitor of kynurenine 3-monooxygenase (KMO; IC50: ~6 nM), an enzyme involved in tryptophan metabolism. | |||
T71069 | GSK1842799 HCl | ||
GSK1842799 is a selective S1P1 receptor agonist for multiple sclerosis. Upon phosphorylation, GSK1842799 showed subnanomole S1P1 agonist activity with >1000× selectivity over S1P3. GSK1842799 demonstrated good oral bioa... | |||
T60252 | HSK16149 | ||
HSK16149 is a novel ligand of voltage-gated calcium channel (VGCC) α 2 δ subunit with analgesic activity. | |||
T64011 | GSK1820795A | ||
GSK1820795A, a telmisartan analog, functions as a selective antagonist of hGPR132a, inhibiting the activation of yeast cells that express hGPR132a by N-acylamides [1]. Additionally, it acts as an angiotensin II antagonis... | |||
T34653 | SK1071 | ||
SK1071 is a novel migrastatin analogs, which demonstrated improved performance over migrastatin, with nanomolar IC50 values in chamber cell migration assays with tumor cells and human umbilical vein endothelial cells (HU... | |||
T68912 | GSK1030058A | ||
GSK1030058A is a novel inhibitor of polo-like kinase | |||
T11477 | GSK1059865 | Others | |
GSK1059865 is a potent antagonist of the orexin 1 receptor. | |||
T38626 | GSK143 | ||
GSK143 is a potent orally active and highly selective inhibitor of spleen tyrosine kinase (SYK) with a pIC 50 of 7.5. Furthermore, GSK143 effectively inhibits phosphorylated Erk (pErk) with a pIC 50 value of 7.1. In addi... | |||
T38619 | GSK1795091 | CRX-601 | |
GSK1795091 (CRX-601) is a synthetic TLR4 agonist and immunologic stimulator with demonstrated antitumor activity. It serves as a vaccine adjuvant, enhancing both mucosal and systemic immunity to influenza virus vaccines. | |||
T32004 | GSK172981 | GSK 172981,GSK-172981 | |
GSK172981 is a non-peptide tachykinin NK3 receptor antagonist with a high affinity for the recombinant human (PK (I) value 7.7) and native guinea pig (PK (I) value 7.8) tachykinin NK3 receptor. In vitro, the functional e... | |||
T32001 | GSK124576A | GSK-124576A,GSK 124576A | |
GSK124576A is a bioactive chemical. | |||
T27451 | GSK1614343 | GSK-1614343,GSK 1614343 | |
GSK1614343 is an antagonist of ghrelin receptor. | |||
T71343 | GSK1997132B | ||
GSK1997132B is a potent, metabolically stable and centrally penetrant PPARγ partial agonist. | |||
T73141 | GSK1790627 | ||
GSK1790627, the N-deacetylated metabolite of Trametinib, represents an orally active MEK inhibitor that promotes autophagy and triggers apoptosis [1]. | |||
T39874 | GSK143 dihydrochloride | ||
GSK143 dihydrochloride is a highly selective, orally active inhibitor of spleen tyrosine kinase (SYK), exhibiting a pIC 50 value of 7.5. It effectively inhibits phosphorylated Erk (pErk) with a pIC 50 value of 7.1. The c... | |||
T11479 | GSK1521498 | Opioid Receptor | |
GSK1521498 is a selective antagonist of the μ-opioid receptor (MOR). It is being used for the treatment of disorders of compulsive consumption of food, alcohol, and drugs. | |||
T15425 | GSK1702934A | Others | |
T32005 | GSK1842799 | GSK 1842799 | |
GSK1842799 is a selective S1P1 receptor agonist with good oral bioavailability. | |||
T71651 | GSK1370319A | ||
GSK1370319A is a potent P2X7 antagonist (IC50 = 3.2 nM). GSK1370319A inhibits ATP-induced increase in IL-1β release and caspase 1 activation in lipopolysaccharide (LPS)-primed mixed glia by blocking assembly of the infla... |
カタログ番号 | 製品名 | Species | Expression System |
---|---|---|---|
TMPY-01635 | PCSK1 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Neuroendocrine convertase 1, also known as Prohormone convertase 1, Proprotein convertase 1, PCSK1 and NEC1, is an enzyme which belongs to the peptidase S8 family and Furin subfamily. PCSK1 is an enzyme that performs the... |